Zynex (ZYXI) Hit by TriCare Suspension on Multiple Fronts: Weak Earnings and Investor Lawsuit – Hagens Berman

SAN FRANCISCO, May 07, 2025 (GLOBE NEWSWIRE) -- Medical technology company Zynex, Inc. (NASDAQ: ZYXI) is facing a double whammy linked to its dealings with TriCare, the healthcare program for the U.S. military community. The company's first-quarter 2025 results revealed a sharp downturn, largely attributed to a temporary payment suspension by one of its major payers, TriCare. Adding to the company’s troubles, this very TriCare payment issue has now become central to a recently announced class action lawsuit ...